Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
IRWD

Market Cap: $671.62M

II

Ironwood Pharmaceuticals, Inc.

IRWD

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin99.76%

EBITDA Margin62.01%

EBIT Margin61.66%

Pre-tax Margin53.27%

Net Profit Margin33.36%

Earnings Yield19.24%

Valuation Multiples

Price / Book-4.17

Price / Sales1.73

Price / Earnings5.13

PEG0.00

Forward PEG1.79

EV / Sales2.54

EV / EBITDA4.10

EV / Operating Cash Flow5.33

EV / Free Cash Flow5.33

Price / Free Cash Flow3.62

Price / Operating Cash Flow3.64

Cash Flow & Capital

Free Cash Flow / Share$1.12

Operating Cash Flow / Share$1.12

Free Cash Flow Yield27.63%

Capex / Revenue0.00%

Capex / Operating Cash Flow0.00%

Capex / Depreciation0.00

Stock Compensation / Revenue5.77%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio6.06

Quick Ratio6.06

Cash Ratio2.41

Debt / Assets1.39

Debt / Capital1.69

Debt / Equity-2.45

Long-Term Debt / Capital1.73

Debt / Market Cap57.32%

Net Debt / EBITDA1.32

Solvency Ratio0.29

Financial Leverage-1.76

Efficiency & Working Capital

Asset Turnover1.37

Fixed Asset Turnover34.28

Inventory Turnover0.00

Receivables Turnover3.45

Payables Turnover1.01

Days Sales Outstanding105.69

Days Inventory Outstanding0

Days Payables Outstanding362.22

Operating Cycle105.69

Cash Conversion Cycle-256.53

Working Capital Turnover2.97

Returns & Quality

Return on Equity-57.40%

Return on Assets45.55%

Return on Invested Capital57.85%

ROCE93.58%

Return on Tangible Assets45.81%

Operating Return on Assets65.60%

Income Quality0.96

Tax Burden0.63

Interest Burden0.86

Balance Sheet & Intrinsic Metrics

Enterprise Value$989.36M

Invested Capital$179.34M

Working Capital$166.35M

Tangible Asset Value$-163.48M

Net Current Asset Value$-247.77M

Graham Net-Net-$1.71

Book Value / Share-$0.98

Tangible Book Value / Share-$0.99

Cash / Share$0.48

Financial Health Scores

Piotroski Score7

Altman Z-Score-2.02

Revenue$389.32M

EBIT$240.04M

Market Cap$671.62M

Working Capital$166.35M

Retained Earnings$-1.58B

Total Assets$285.13M

Total Liabilities$446.97M